Diabetic patients with COVID-19: low antibody levels linked to worse outcomes

As Con­gress re­turns from Au­gust re­cess, phar­ma and health in­dus­try groups are mak­ing cas­es for why health­care costs should be low­er or more trans­par­ent aimed

Fer­ring Phar­ma­ceu­ti­cals is pulling in $300 mil­lion and a po­ten­tial $200 mil­lion mile­stone from Roy­al­ty Phar­ma in ex­change for a 5.1% per­cent­age roy­al­ty on net